The short version

Scott Galloway predicted on January 5, 2024: “He notes that “the rate of AI mentions in S&P 500 earnings calls dropped from 35% to 29%”, supporting a thesis of “Peak AI”. ... Galloway erwartet, dass GLP1 … die Technologie des Jahres 2024 wird.” Verdict: Partially right. AI hype moderation and earnings call mentions fluctuated, but AI investment and deployment continued…

Prediction by

Scott Galloway

On January 5, 2024

“He notes that “the rate of AI mentions in S&P 500 earnings calls dropped from 35% to 29%”, supporting a thesis of “Peak AI”. ... Galloway erwartet, dass GLP1 … die Technologie des Jahres 2024 wird.”

Follow-up

AI hype moderation and earnings call mentions fluctuated, but AI investment and deployment continued to grow into 2025-2026, so AI did not 'peak' in a structural sense. GLP-1-based drugs were indeed highly impactful in healthcare and consumer markets, widely validating his 'tech of the year' call for 2024-2025.

From the High Caliber AI network — see the AI for PR module in the course.